Pharmena S.A. (WSE:PHR)
3.260
0.00 (0.00%)
Sep 4, 2026, 2:27 PM CET
Pharmena Revenue
Pharmena had revenue of 242.00K PLN in the quarter ending June 30, 2026, a decrease of -37.31%. This brings the company's revenue in the last twelve months to 1.46M, up 64.34% year-over-year. In the year 2025, Pharmena had annual revenue of 1.58M with 488.43% growth.
Revenue (ttm)
1.46M
Revenue Growth
+64.34%
P/S Ratio
24.85
Revenue / Employee
208.71K
Employees
7
Market Cap
36.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58M | 1.31M | 488.43% |
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
| Dec 31, 2023 | 299.00K | - | - |
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 266.02M |
| Ryvu Therapeutics | 88.38M |
| Synthaverse | 42.19M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Urteste | 2.50M |
| Captor Therapeutics Spolka Akcyjna | 2.38M |
| Poltreg | 250.00K |